Moving towards the global HIV 95% viral suppression target

Lancet HIV. 2021 Dec;8(12):e731-e732. doi: 10.1016/S2352-3018(21)00273-3.

Authors

Pascal O Bessong¹, Lufuno G Mavhandu-Ramarumo²

Affiliations

¹ AIDS Virus Research Laboratory, HIV/AIDS and Global Health Research Programme, University of Venda, Thohoyandou 0950, South Africa; Center for Global Health Equity, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA. Electronic address: bessong@univen.ac.za.
² AIDS Virus Research Laboratory, HIV/AIDS and Global Health Research Programme, University of Venda, Thohoyandou 0950, South Africa.

PMID: 34856177
DOI: 10.1016/S2352-3018(21)00273-3

No abstract available

Publication types

Comment

MeSH terms

Anti-Retroviral Agents / therapeutic use
HIV Infections* / drug therapy
HIV Infections* / epidemiology
HIV Infections* / prevention & control
Humans
Viral Load

Substances

Anti-Retroviral Agents